| PERIOD ENDING | 29-Aug-09 | 30-May-09 | 28-Feb-09 | 29-Nov-08 | | Total Revenue | 315,329 | 299,194 | 278,563 | 350,155 | | Cost of Revenue | 214,914 | 209,786 | 203,564 | 262,893 | | | Gross Profit | 100,415 | 89,408 | 74,999 | 87,262 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 52,182 | 60,464 | 63,658 | 62,824 | | Non Recurring |
-
|
-
| 790 | 87,392 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,233 | 28,944 | 10,551 | (62,954) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,345 | (2,345) |
-
| 2,718 | | Earnings Before Interest And Taxes | 50,578 | 26,599 | 10,551 | (63,065) | | Interest Expense | 1,680 | 2,188 | 2,398 | 3,991 | | Income Before Tax | 48,898 | 24,411 | 8,153 | (67,056) | | Income Tax Expense | 15,113 | 8,054 | 3,008 | (23,512) | | Minority Interest | (49) | 95 | 10 | 5 | | | | Net Income From Continuing Ops | 35,413 | 17,558 | 6,116 | (42,406) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 35,413 | 17,558 | 6,116 | (42,406) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $35,413 | $17,558 | $6,116 | ($42,406) |
|
0.51% Nasdaq 
Income Statement
